Skip to content

Clinical Study of PRP in the Treatment of Androgenetic Alopecia

The Application of Platelet-rich Plasma in the Treatment of Androgenic Alopecia:a Prospective Clinical Random Study.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07551271
Enrollment
30
Registered
2026-04-24
Start date
2025-01-01
Completion date
2026-03-01
Last updated
2026-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenetic Alopecia (AGA)

Keywords

Androgenetic alopecia, Platelet-rich plasma, Minoxidil, Dermoscpe

Brief summary

A study on the therapeutic effect of platelet-rich plasma in the treatment of androgenetic alopecia

Detailed description

This study included 30 patients with moderate and severe androgenic alopecia and randomly divided into two groups, group A was treated with platelet-rich plasma (once 4 weeks for 3 times) combined with external Minoxidil(5% for male, 2% for female, twice a day, 1 ml each time) , group B was treated with external Minoxidil. The patients in both groups were examined by dermoscopy before the first treatment and 1,2,3 and 6 months after the treatment. The scalp MRI was performed before the first treatment and 6 months after the treatment, the number, density and depth of hair follicles were measured to evaluate the efficacy and safety of platelet-rich plasma combined with Minoxidil in the treatment of androgenic alopecia.

Interventions

DRUGPRP

group A was treated with platelet-rich plasma combined with external Minoxidil , group B was treated with external Minoxidil

Sponsors

The First Affiliated Hospital of Soochow University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* moderate to severe androgenic Alopecia

Exclusion criteria

* abnormal coagulation

Design outcomes

Primary

MeasureTime frameDescription
Dermoscopebefore the first treatment and 1,2,3 and 6 months after the treatmentThe amount of hair on the parietal and posterior occipital regions
MRIbefore the first treatment and 6 months after the treatmentHair follicle density on the parietal and posterior occipital regions

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 25, 2026